Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox Injections in Non-Cranial Nerve VII Innervated Muscles for Facial Synkinesis Management
NCT07295288Phase 4Withdrawn
- Sponsor
- Vanderbilt University Medical Center
- Start
- Jul 2026
- Primary completion
- Jun 2027
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 4 trial of botulinum toxin type A in Synkinesis, sponsored by Vanderbilt University Medical Center. Planned start Jul 2026; status: withdrawn.
02
Drugs
botulinum toxin type A
03
Conditions
Synkinesis
Beyond the preview
Go deeper on NCT07295288.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07295288.